Piper Sandler Has Lowered Expectations for Sarepta Therapeutics (NASDAQ:SRPT) Stock Price
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target dropped by investment analysts at Piper Sandler from $182.00 to $110.00 in a report issued on Monday,Benzinga reports. The firm currently has an “overweight” rating on the biotechnology company’s stock. Piper Sandler’s price target suggests a potential upside of 85.47% from the stock’s previous […]
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target dropped by investment analysts at Piper Sandler from $182.00 to $110.00 in a report issued on Monday,Benzinga reports. The firm currently has an “overweight” rating on the biotechnology company’s stock. Piper Sandler’s price target suggests a potential upside of 85.47% from the stock’s previous […]
